Benzoyl Peroxide; Clindamycin Phosphate Global Patent Coverage & Expiry Overview

Track protection status across key markets to assess launch feasibility.

Start your free 7-Day Trial! Book a demo to explore our global patent data.

It is formulated by 8 pharmaceutical companies such as PADAGIS ISRAEL, BAUSCH, ACTAVIS LABS UT INC and others. It is marketed under 3 brand names, including CLINDAMYCIN PHOSPHATE AND BENZOYL PEROXIDE, ONEXTON, CABTREO. Available in 5 different strengths, such as 5%;1.2%, 3.75%;EQ 1.2% BASE, 2.5%;EQ 1.2% BASE and others, and administered through 1 route including GEL;TOPICAL.

Strategic Dashboard

info

insightsStrategic Insights

Sourcing & Feasibility

check_circle API availability: autorenew Loading API feasibility...

groups Licensing: 8 potential partners

calendar_todayUS Launch window: autorenew Loading launch window...

timeline Key Patent Barrier & Expiry Timeline

autorenew Loading patent barriers...

factoryGeneric Manufacturer Snapshot

autorenew Loading manufacturers...

gavelRisk & Opportunity Summary

dangerous Risk: autorenew Loading risk analysis...
watch_later Watch: autorenew Loading watch analysis...
rocket_launch Opportunity: autorenew Loading opportunity analysis...
flag
gavel
calendar_today
calendar_today

Access Global Patent Data

Stay ahead with worldwide patent expiry and latest updates.

Comprehensive global patent expiry timelines
Full patent family details and status updates

Orange Book Drug Approval Timeline

FDA approval history for this ingredient

NDA (New Drug Application) ANDA (Generic Application)

Access Global Exclusivity and Patent Expiry Extensions

Stay ahead with worldwide patent expiry insights, exclusivity data, and latest updates.

Comprehensive global patent expiry timelines
Full patent family details and status updates
Latest exclusivity data and extensions

US Orange Book Patents Expiration Timeline

Key expiration dates for US patents covering this ingredient

View Global Patents Expiration Timeline

Stay ahead with worldwide patent expiry insights, market data, and research updates.

Comprehensive global patent expiry timelines
Full patent family details and status updates

Orange Book Drug Strengths

Latest drug strengths approved by FDA

Strength Route of Administration Companies Latest Approval Date

Orange Book Patents

Patents approved by the FDA for the ingredient

Patent Number Publication Date Legal Status Patent Expiry Date
{"application_id":"59262","ingredient":"BENZOYL PEROXIDE; CLINDAMYCIN PHOSPHATE","trade_name":"ONEXTON","family_id":"62cb2cf4a5b3443f9c5d","publication_number":"US10137142B2","cleaned_patent_number":"10137142","drug_product_flag":"Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2029-06-03","publication_date":"2018-11-27","legal_status":"Granted"} US10137142B2 Formulation 27 Nov, 2018 Granted 03 Jun, 2029
{"application_id":"59263","ingredient":"ADAPALENE; BENZOYL PEROXIDE; CLINDAMYCIN PHOSPHATE","trade_name":"ACANYA","family_id":"62cb2cf4a5b3443f9c5d","publication_number":"US10220049B2","cleaned_patent_number":"10220049","drug_product_flag":"Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2029-06-03","publication_date":"2019-03-05","legal_status":"Granted"} US10220049B2 Formulation 05 Mar, 2019 Granted 03 Jun, 2029
{"application_id":"59264","ingredient":"ADAPALENE; BENZOYL PEROXIDE; CLINDAMYCIN PHOSPHATE","trade_name":"ACANYA","family_id":"62cb2cf4a5b3443f9c5d","publication_number":"US10624918B2","cleaned_patent_number":"10624918","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2029-06-03","publication_date":"2020-04-21","legal_status":"Granted"} US10624918B2 21 Apr, 2020 Granted 03 Jun, 2029
{"application_id":"59256","ingredient":"BENZOYL PEROXIDE; CLINDAMYCIN PHOSPHATE","trade_name":"ACANYA","family_id":"62cb2cf4a5b3443f9c5d","publication_number":"US8663699B2","cleaned_patent_number":"8663699","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2029-06-03","publication_date":"2014-03-04","legal_status":"Granted"} US8663699B2 04 Mar, 2014 Granted 03 Jun, 2029
{"application_id":"59257","ingredient":"BENZOYL PEROXIDE; CLINDAMYCIN PHOSPHATE","trade_name":"ACANYA","family_id":"62cb2cf4a5b3443f9c5d","publication_number":"US8895070B2","cleaned_patent_number":"8895070","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2029-06-03","publication_date":"2014-11-25","legal_status":"Granted"} US8895070B2 25 Nov, 2014 Granted 03 Jun, 2029
{"application_id":"59258","ingredient":"BENZOYL PEROXIDE; CLINDAMYCIN PHOSPHATE","trade_name":"ACANYA","family_id":"62cb2cf4a5b3443f9c5d","publication_number":"US9078870B2","cleaned_patent_number":"9078870","drug_product_flag":"Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2029-06-03","publication_date":"2015-07-14","legal_status":"Granted"} US9078870B2 Formulation 14 Jul, 2015 Granted 03 Jun, 2029
{"application_id":"59259","ingredient":"BENZOYL PEROXIDE; CLINDAMYCIN PHOSPHATE","trade_name":"ONEXTON","family_id":"62cb2cf4a5b3443f9c5d","publication_number":"US9504704B2","cleaned_patent_number":"9504704","drug_product_flag":"Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2029-06-03","publication_date":"2016-11-29","legal_status":"Granted"} US9504704B2 Formulation 29 Nov, 2016 Granted 03 Jun, 2029
{"application_id":"59260","ingredient":"ADAPALENE; BENZOYL PEROXIDE; CLINDAMYCIN PHOSPHATE","trade_name":"CABTREO","family_id":"62cb2cf4a5b3443f9c5d","publication_number":"US9561208B2","cleaned_patent_number":"9561208","drug_product_flag":"Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2029-06-03","publication_date":"2017-02-07","legal_status":"Granted"} US9561208B2 Formulation 07 Feb, 2017 Granted 03 Jun, 2029
{"application_id":"59241","ingredient":"ADAPALENE; BENZOYL PEROXIDE; CLINDAMYCIN PHOSPHATE","trade_name":"ACANYA","family_id":"62cb2cf4a5b3443f9c5d","publication_number":"US8288434B2","cleaned_patent_number":"8288434","drug_product_flag":"Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2029-08-05","publication_date":"2012-10-16","legal_status":"Granted"} US8288434B2 Formulation 16 Oct, 2012 Granted 05 Aug, 2029
{"application_id":"117269","ingredient":"ADAPALENE; BENZOYL PEROXIDE; CLINDAMYCIN PHOSPHATE","trade_name":"CABTREO","family_id":"d5b7f1bcdb3c49ca8fe4","publication_number":"US2022370315A1","cleaned_patent_number":"12128059","drug_product_flag":"Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2040-07-31","publication_date":"2024-10-29","legal_status":"Granted"} US12128059B2 Formulation 29 Oct, 2024 Granted 31 Jul, 2040
{"application_id":"138479","ingredient":"ADAPALENE; BENZOYL PEROXIDE; CLINDAMYCIN PHOSPHATE","trade_name":"CABTREO","family_id":"d5b7f1bcdb3c49ca8fe4","publication_number":"","cleaned_patent_number":"12133859","drug_product_flag":"Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2040-07-31","publication_date":"2024-11-05","legal_status":"Patented case"} US12133859B2 Formulation 05 Nov, 2024 Patented case 31 Jul, 2040
{"application_id":"138478","ingredient":"ADAPALENE; BENZOYL PEROXIDE; CLINDAMYCIN PHOSPHATE","trade_name":"CABTREO","family_id":"d5b7f1bcdb3c49ca8fe4","publication_number":"","cleaned_patent_number":"12138278","drug_product_flag":"Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2040-07-31","publication_date":"2024-11-12","legal_status":"Patented case"} US12138278B2 Formulation 12 Nov, 2024 Patented case 31 Jul, 2040
{"application_id":"117261","ingredient":"ADAPALENE; BENZOYL PEROXIDE; CLINDAMYCIN PHOSPHATE","trade_name":"CABTREO","family_id":"d5b7f1bcdb3c49ca8fe4","publication_number":"US11389467B2","cleaned_patent_number":"11389467","drug_product_flag":"Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2040-12-28","publication_date":"2022-07-19","legal_status":"Granted"} US11389467B2 Formulation 19 Jul, 2022 Granted 28 Dec, 2040

Recent Clinical Trials

Latest clinical trials and research studies for this ingredient

NCT ID Title Status Phase Conditions Start Date Completion Date

API Suppliers/Manufacturer (Branded/Generic companies)

Manufacturing Locations

View Complete Supplier List

Unlock access to all suppliers of Benzoyl Peroxide; Clindamycin Phosphate

Access a comprehensive list of global suppliers
Get information on each supplier

Note: Patent expirations and exclusivity timelines are dynamic and may shift based on litigation, regulatory extensions, and maintenance filings. Regular monitoring is advised.